Korean J Nephrol.  2009 Sep;28(5):508-513.

Successful Treatment of Hypercalcemia During Continuous Renal Replacement Therapy in Patient with Rhabdomyolysis Following Cardioversion and Cardiopulmonary Resuscitation

• Park JM
• Chon GR
• Wang JH
• Lee TU
• Lee WS

Abstract

Rhabdomyolysis is a common clinical and laboratory syndrome resulting from reversible skeletal muscle injury, with release of muscle cell contents into the plasma. Cardioversion, and cardiopulmonary resuscitation may produce rhabdomyolysis and myoglobinuria. We report a 5-year-old boy surviving after cardiopulmonary resuscitation and repeated 5 times of cardioversion. He showed elevated serum BUN and creatinine levels, requiring hemodialysis treatment. We had tried 5 times of intermittent hemodialysis, but oliguria was continued and there was no change of serum BUN and creatinine. His urine output was less than 100 cc per day and he showed severe edema and weight gain of 7 kg, and so we started the continuous renal replacement therapy (Prismaflex(R), gambro). After 12 days of continuous venovenous hemodiafiltration (CVVHDF), his urine output recovered and his BUN, creatinine, liver enzyme, creatine kinase, and lactate dehydrogenase levels returned to normal. During the treatment of CVVHDF, he had shown persistent hypercalcemia, and so we changed dialysate and replacement solution from hemosol B0 to calcium free solution. The hypercalcemia was controlled successfully using this calcium free pharmacy-made bicarbonate solution.

Keyword

Rhabdomyolysis; Cardiopulmonary resuscitation; Cardioversion; Hemodiafiltration; Hypercalcemia

MeSH Terms

Calcium
Cardiopulmonary Resuscitation
Creatine Kinase
Creatinine
Edema
Electric Countershock
Hemodiafiltration
Humans
Hypercalcemia
L-Lactate Dehydrogenase
Liver
Muscle Cells
Muscle, Skeletal
Myoglobinuria
Oliguria
Plasma
Preschool Child
Renal Dialysis
Renal Replacement Therapy
Rhabdomyolysis
Weight Gain
Calcium
Creatine Kinase
Creatinine
L-Lactate Dehydrogenase